The DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.
Effect of Pneumococcal Conjugate Vaccination on Serotype-Specific Carriage and Invasive Disease in England: A Cross-Sectional Study
Open accessAbstract
BACKGROUND: We investigated the effect of the 7-valent pneumococcal conjugate vaccine (PCV7) programme in England on serotype-specific carriage and invasive disease to help understand its role in serotype replacement and predict the impact of higher valency vaccines. METHODS AND FINDINGS: Nasopharyngeal swabs were taken from children <5 y old and family members (n=400) 2 y after introduction of PCV7 into routine immunization programs. Proportions carrying Streptococcus pneumoniae and serotype distribution among carried isolates were compared with a similar population prior to PCV7 introduction. Serotype-specific case carrier ratios (CCRs) were estimated using national data on invasive disease. In vaccinated children and their contacts vaccine-type (VT) carriage decreased, but was offset by an increase in non-VT carriage, with no significant overall change in carriage prevalence, odds ratio 1.06 (95% confidence interval 0.76-1.49). The lower CCRs of the replacing serotypes resulted in a net reduction in invasive disease in children. The additional serotypes covered by higher valency vaccines had low carriage but high disease prevalence. Serotype 11C emerged as predominant in carriage but caused no invasive disease whereas 8, 12F, and 22F emerged in disease but had very low carriage prevalence. CONCLUSION: Because the additional serotypes included in PCV10/13 have high CCRs but low carriage prevalence, vaccinating against them is likely to significantly reduce invasive disease with less risk of serotype replacement. However, a few serotypes with high CCRs could mitigate the benefits of higher valency vaccines. Assessment of the effect of PCV on carriage as well as invasive disease should be part of enhanced surveillance activities for PCVs. Please see later in the article for the Editors' Summary.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
SIMPSON, E. H. (1949) · Nature · doi:10.1038/163688a0 · Cited by 14,164
Efficacy, safety and immunogenicity of heptavalent pneumococcal conjugate vaccine in children
BLACK, S., SHINEFIELD, H., FIREMAN, B., LEWIS, E., RAY, P., HANSEN, J. R., ELVIN, L., ENSOR, K. M., HACKELL, J., SIBER, G., et al. (2000) · The Pediatric Infectious Disease Journal · doi:10.1097/00006454-200003000-00003 · Cited by 2,293
Sustained Reductions in Invasive Pneumococcal Disease in the Era of Conjugate Vaccine
Pilishvili, T., Lexau, C., Farley, M. M., Hadler, J., Harrison, L. H., Bennett, N. M., Reingold, A., Thomas, A., Schaffner, W., Craig, A. S., et al. (2010) · The Journal of Infectious Diseases · doi:10.1086/648593 · Cited by 1,311
Gray, B. M., Converse, G. M., & Dillon, H. C. (1980) · Journal of Infectious Diseases · doi:10.1093/infdis/142.6.923 · Cited by 796
Miller, E., Andrews, N. J., Waight, P. A., Slack, M. P., & George, R. C. (2011) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(11)70090-1 · Cited by 643
Self-citationBrueggemann, A. B., Griffiths, D. T., Meats, E., Peto, T., Crook, D. W., & Spratt, B. G. (2003) · The Journal of Infectious Diseases · doi:10.1086/374624 · Cited by 619
Dagan, R., Melamed, R., Muallem, M., Piglansky, L., Greenberg, D., Abramson, O., Mendelman, P. M., Bohidar, N., & Yagupsky, P. (1996) · Journal of Infectious Diseases · doi:10.1093/infdis/174.6.1271 · Cited by 477
Association of Serotype with Risk of Death Due to Pneumococcal Pneumonia: A Meta‐Analysis
Weinberger, D. M., Harboe, Z. B., Sanders, E. A. M., Ndiritu, M., Klugman, K. P., Rückinger, S., Dagan, R., Adegbola, R., Cutts, F., Johnson, H. L., et al. (2010) · Clinical Infectious Diseases · doi:10.1086/655828 · Cited by 343
Dagan, R., Givon‐Lavi, N., Zamir, O., Sikuler‐Cohen, M., Guy, L., Janco, J., Yagupsky, P., & Fraser, D. (2002) · The Journal of Infectious Diseases · doi:10.1086/339525 · Cited by 339
Chapter XI Laboratory Diagnosis, Serology and Epidemiology of Streptococcus pneumoniae
Lund, E., & Henrichsen, J. (1978) · Methods in microbiology · doi:10.1016/s0580-9517(08)70365-9 · Cited by 323
Cited by
Miller, E., Andrews, N. J., Waight, P. A., Slack, M. P., & George, R. C. (2011) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(11)70090-1 · Cited by 643
Self-citationWaight, P. A., Andrews, N. J., Ladhani, S. N., Sheppard, C. L., Slack, M. P. E., & Miller, E. (2015) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(15)70044-7 · Cited by 589
Self-citationLadhani, S. N., Collins, S., Djennad, A., Sheppard, C. L., Borrow, R., Fry, N. K., Andrews, N. J., Miller, E., & Ramsay, M. E. (2018) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(18)30052-5 · Cited by 559
Self-citationSatzke, C., Turner, P., Virolainen-Julkunen, A., Adrian, P. V., Antonio, M., Hare, K. M., Henao-Restrepo, A. M., Leach, A. J., Klugman, K. P., Porter, B. D., et al. (2013) · Vaccine · doi:10.1016/j.vaccine.2013.08.062 · Cited by 478
Feikin, D. R., Kagucia, E. W., Loo, J. D., Link-Gelles, R., Puhan, M. A., Cherian, T., Levine, O. S., Whitney, C. G., O’Brien, K. L., Moore, M. R., et al. (2013) · PLoS Medicine · doi:10.1371/journal.pmed.1001517 · Cited by 470
“Increases in NVT IPD following routine introduction of PCV7 were presumed to represent serotype replacement of VT by NVT, a phenomenon well-documented in pneumococcal nasopharyngeal colonization from randomized controlled trials [5] and observational studies [6,7].”
BackgroundInfluentialEffect of vaccines on bacterial meningitis worldwide
McIntyre, P. B., O'Brien, K. L., Greenwood, B., & van de Beek, D. (2012) · The Lancet · doi:10.1016/s0140-6736(12)61187-8 · Cited by 326
van Hoek, A. J., Andrews, N., Waight, P. A., Stowe, J., Gates, P., George, R., & Miller, E. (2012) · Journal of Infection · doi:10.1016/j.jinf.2012.02.017 · Cited by 253
Self-citationWeinberger, D. M., Simonsen, L., Jordan, R., Steiner, C., Miller, M., & Viboud, C. (2012) · The Journal of Infectious Diseases · doi:10.1093/infdis/jir749 · Cited by 132
“Also, the new formulation of the pneumococcal conjugate vaccine, which promises to further reduce disease incidence and transmission of highly invasive serotypes [41, 42], could help to reduce the impacts of future pandemics.”
BackgroundSpijkerman, J., Prevaes, S. M. P. J., van Gils, E. J. M., Veenhoven, R. H., Bruin, J. P., Bogaert, D., Wijmenga-Monsuur, A. J., van den Dobbelsteen, G. P. J. M., & Sanders, E. A. M. (2012) · PLoS ONE · doi:10.1371/journal.pone.0039730 · Cited by 126
“Consistent with reports from other countries, 19A became the most predominant colonizing serotype in all investigated age groups in the Netherlands, followed by 6C, 15B/C and 11A [39,40].”
ResultThors, V., Christensen, H., Morales-Aza, B., Vipond, I., Muir, P., & Finn, A. (2016) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201510-2000oc · Cited by 44
“wide effects on carriage and transmission (1).”
Adamu, A. L., Ojal, J., Abubakar, I. A., Odeyemi, K. A., Bello, M. M., Okoromah, C. A. N., Karia, B., Karani, A., Akech, D., Inem, V., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-38277-z · Cited by 18
Metadata
- Authors
- Flasche, S., Van Hoek, A. J., Sheasby, E., Waight, P., Andrews, N., Sheppard, C., George, R., & Miller, E.
- Venue
- PLoS Medicine
- Publisher
- Public Library of Science (PLoS)
- Published
- 2011-04-05
- Volume
- 8
- Issue
- 4
- Pages
- e1001017
- ISSN
- 1549-1277 (ISSN-L)
- 1549-1676
- OpenAlex
- W2053889461
- Cited by
- 277
- References
- 30
- FWCI
- 20.32
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.